missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human STRN3 (aa 204-342) Control Fragment Recombinant Protein
Click to view available options
Quantité:
100 μl
Conditionnement:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (95%), Rat (95%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-52085 (PA5-52085. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
SG2NA was identified as a human cancer autoantigen and has now been implicated in vesicular trafficking and signal transduction. It is highly related to striatin and zinedin. It is a scaffolding protein that binds PP2A A and C subunits as well as the human homolog of the yeast protein, Mob1, which has been implicated in control of mitotic progression in yeast. It also binds calmodulin and appears to modulate PP2A activity.
Spécification
Spécification
| Numéro d’adhésion | Q13033 |
| Concentration | ≥5.0 mg/mL |
| À utiliser avec (application) | Blocking Assay, Control |
| Formule | 1 M urea, PBS with no preservative; pH 7.4 |
| Identification génétique (Entrez) | 29966 |
| Nom | Human STRN3 (aa 204-342) Control Fragment |
| Quantité | 100 μl |
| État réglementaire | RUO |
| Alias de gène | Cell cycle autoantigen SG2NA; cell cycle S/G2 nuclear autoantigen; cell-cycle autoantigen SG2NA; Gs2na; nuclear autoantigen; PPP2R6B; protein phosphatase 2 regulatory subunit B'''beta; s/G2 antigen; Sg2na; SG2NA beta isoform; striatin 3; striatin, calmodulin binding protein 3; striatin-3; striatin-3 35 kDa; striatin-3-gamma; Strn3 |
| Nom usuel | STRN3 |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu